The greater frequency of Th9 cells among the RA patients was not associated with higher ANA or other autoantibody levels, disease duration, baseline CRP-DAS28, nor was it associated with the reason for discontinuing infliximab or the number of previous biological drugs administered to the non-responders. This evidence concerns the gene CRP and rheumatoid arthritis.